Acurx Pharmaceuticals Secures Japanese Patent for DNA Polymerase IIIC Inhibitors
Acurx Pharmaceuticals has secured a new patent from the Japanese Patent Office for its DNA Polymerase IIIC Inhibitors, expanding its global intellectual property portfolio in antimicrobial drug development.
Japanese Patent Office | 20/02/2025 | By Abha
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy